Investing Profile

Megan Blewett

Investor
Life Sciences Investor at Venrock
San Francisco Bay Area
Photo of Megan Blewett, Investor at Venrock

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Harvard University Network
898 CONNECTIONS
Harvard University Network
898 CONNECTIONS
Venrock Network
47 CONNECTIONS
Venrock Network
47 CONNECTIONS
Broad Institute of MIT and Harvard Network
36 CONNECTIONS
cb
Venrock Investor
$10K - $100K
$50K
$450M
Co-founder & BD Stealth Company (Megan Blewett)Present
Co-Founder and Director of Business Development Kelonia TherapeuticsPresent
Co-Founder and VP Corporate Development Iris MedicinePresent
Co-Founder and President Iris MedicinePresent
Board Member Convergent ResearchPresent
Principal Scion Life SciencesPresent
Board Member Hertz FoundationPresent
Life Sciences Investor VenrockPresent
Research Intern Broad Institute of MIT and HarvardPresent
Research Assistant Corey Lab, Harvard UniversityPresent
Working on early-stage biotech companies Stealth NewCoPresent
Life sciences investor Venrock2017 - 2020
Harvard University AB/AM Chemistry
The Scripps Research Institute Doctor of Philosophy (Ph.D.) Chemistry
Scripps Research Doctor of Philosophy (Ph.D.) Chemistry
The Scripps Research Institute doctorates, doctor of philosophy biology, philosophy, chemistry, immunology
Harvard University master of arts, masters, bachelors, bachelor of arts chemistry
Sign in with Google →
Sign in with Google →